S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
BABA   212.59 (-2.50%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
F   7.89 (-1.74%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
BAC   34.36 (-1.41%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
BABA   212.59 (-2.50%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
F   7.89 (-1.74%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
BAC   34.36 (-1.41%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
BABA   212.59 (-2.50%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
F   7.89 (-1.74%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
BAC   34.36 (-1.41%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
S&P 500   3,337.75 (-1.05%)
DOW   28,992.41 (-0.78%)
QQQ   230.27 (-1.92%)
AAPL   313.05 (-2.26%)
FB   210.18 (-2.05%)
MSFT   178.59 (-3.16%)
GOOGL   1,483.46 (-2.21%)
AMZN   2,095.97 (-2.65%)
CGC   21.88 (-1.93%)
NVDA   294.07 (-4.74%)
BABA   212.59 (-2.50%)
MU   56.99 (-3.41%)
GE   12.25 (-2.23%)
TSLA   901.00 (+0.18%)
AMD   53.28 (-6.97%)
T   38.55 (-0.16%)
ACB   1.67 (-0.60%)
F   7.89 (-1.74%)
NFLX   380.07 (-1.54%)
PRI   132.33 (-2.98%)
BAC   34.36 (-1.41%)
DIS   138.97 (-1.00%)
GILD   69.70 (+4.03%)
Log in

NYSE:KDMN - Kadmon Stock Price, Forecast & News

$5.07
+0.02 (+0.40 %)
(As of 02/21/2020 04:00 PM ET)
Today's Range
$4.94
Now: $5.07
$5.19
50-Day Range
$4.21
MA: $4.57
$5.14
52-Week Range
$1.63
Now: $5.07
$5.38
Volume1.87 million shs
Average Volume1.75 million shs
Market Capitalization$657.53 million
P/E RatioN/A
Dividend YieldN/A
Beta2.47
Kadmon Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes small molecules and biologics primarily for the treatment of inflammatory and fibrotic diseases. The company markets and distributes products in various therapeutic areas, including ribavirin products for chronic hepatitis C virus infection; and distributes products in various therapeutic areas, including tetrabenazine for the treatment of chorea associated with Huntington's disease. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone212-308-6000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.40 million
Book Value$0.41 per share

Profitability

Net Income$-54,250,000.00
Net Margins-9,855.14%

Miscellaneous

Employees116
Market Cap$657.53 million
Next Earnings Date3/5/2020 (Estimated)
OptionableOptionable

Receive KDMN News and Ratings via Email

Sign-up to receive the latest news and ratings for KDMN and its competitors with MarketBeat's FREE daily newsletter.


Kadmon (NYSE:KDMN) Frequently Asked Questions

What is Kadmon's stock symbol?

Kadmon trades on the New York Stock Exchange (NYSE) under the ticker symbol "KDMN."

How were Kadmon's earnings last quarter?

Kadmon Holdings Inc (NYSE:KDMN) issued its quarterly earnings results on Thursday, August, 9th. The company reported $0.24 EPS for the quarter, beating the consensus estimate of ($0.26) by $0.50. The firm earned $0.36 million during the quarter, compared to analysts' expectations of $0.90 million. Kadmon had a negative return on equity of 188.03% and a negative net margin of 9,855.14%. View Kadmon's Earnings History.

When is Kadmon's next earnings date?

Kadmon is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for Kadmon.

What price target have analysts set for KDMN?

5 brokerages have issued 12-month price objectives for Kadmon's stock. Their forecasts range from $2.77 to $25.00. On average, they expect Kadmon's stock price to reach $10.75 in the next twelve months. This suggests a possible upside of 112.1% from the stock's current price. View Analyst Price Targets for Kadmon.

What is the consensus analysts' recommendation for Kadmon?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Kadmon in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Kadmon.

Has Kadmon been receiving favorable news coverage?

News articles about KDMN stock have trended somewhat positive on Friday, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Kadmon earned a media sentiment score of 0.6 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 7.0 out of 10, indicating that recent news coverage is likely to have an impact on the stock's share price in the near future. View News Stories for Kadmon.

Are investors shorting Kadmon?

Kadmon saw a increase in short interest in January. As of January 15th, there was short interest totalling 14,130,000 shares, an increase of 46.1% from the December 31st total of 9,670,000 shares. Based on an average daily trading volume, of 1,790,000 shares, the short-interest ratio is presently 7.9 days. Currently, 12.1% of the shares of the stock are sold short. View Kadmon's Current Options Chain.

Who are some of Kadmon's key competitors?

What other stocks do shareholders of Kadmon own?

Who are Kadmon's key executives?

Kadmon's management team includes the folowing people:
  • Dr. Harlan W. Waksal, Pres, CEO & Director (Age 66)
  • Mr. Steven Meehan, Exec. VP & CFO (Age 54)
  • Mr. Steven N. Gordon, Chief Admin., Compliance & Legal Officer, Exec. VP & Gen. Counsel (Age 51)
  • Ms. Cynthia L. Schwalm, Director (Age 59)
  • Mr. Kyle Carver, Controller & Principal Accounting Officer

When did Kadmon IPO?

(KDMN) raised $101 million in an initial public offering (IPO) on Wednesday, July 27th 2016. The company issued 5,600,000 shares at $16.00-$20.00 per share. Citigroup and Jefferies served as the underwriters for the IPO and JMP Securities and H.C. Wainwright & Co. were co-managers.

Who are Kadmon's major shareholders?

Kadmon's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Perceptive Advisors LLC (11.29%), Boxer Capital LLC (4.79%), State Street Corp (2.67%), Sofinnova Investments Inc. (1.83%), Geode Capital Management LLC (1.45%) and Schonfeld Strategic Advisors LLC (0.73%). View Institutional Ownership Trends for Kadmon.

Which institutional investors are selling Kadmon stock?

KDMN stock was sold by a variety of institutional investors in the last quarter, including Sofinnova Investments Inc., Goldman Sachs Group Inc., Quantitative Systematic Strategies LLC, Bank of America Corp DE, Algert Global LLC and Principal Financial Group Inc.. View Insider Buying and Selling for Kadmon.

Which institutional investors are buying Kadmon stock?

KDMN stock was purchased by a variety of institutional investors in the last quarter, including Boxer Capital LLC, Perceptive Advisors LLC, State Street Corp, Schonfeld Strategic Advisors LLC, EAM Global Investors LLC, Panagora Asset Management Inc., EAM Investors LLC and Credit Suisse AG. View Insider Buying and Selling for Kadmon.

How do I buy shares of Kadmon?

Shares of KDMN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Kadmon's stock price today?

One share of KDMN stock can currently be purchased for approximately $5.07.

How big of a company is Kadmon?

Kadmon has a market capitalization of $657.53 million and generates $1.40 million in revenue each year. The company earns $-54,250,000.00 in net income (profit) each year or ($1.03) on an earnings per share basis. Kadmon employs 116 workers across the globe.View Additional Information About Kadmon.

What is Kadmon's official website?

The official website for Kadmon is http://www.kadmon.com/.

How can I contact Kadmon?

Kadmon's mailing address is 450 East 29th Street, New York NY, 10016. The company can be reached via phone at 212-308-6000 or via email at [email protected]


MarketBeat Community Rating for Kadmon (NYSE KDMN)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  240 (Vote Outperform)
Underperform Votes:  223 (Vote Underperform)
Total Votes:  463
MarketBeat's community ratings are surveys of what our community members think about Kadmon and other stocks. Vote "Outperform" if you believe KDMN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KDMN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/21/2020 by MarketBeat.com Staff

Featured Article: What is a stock split?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel